| The impact of rotavirus vaccination on discounted net tax revenue in Egypt: a government perspective analysis MP Connolly, O Topachevskyi, B Standaert, O Ortega, M Postma Pharmacoeconomics 30, 681-695, 2012 | 47 | 2012 |
| Cost-effectiveness and cost utility analysis of three pneumococcal conjugate vaccines in children of Peru JA Gomez, JC Tirado, AA Navarro Rojas, MM Castrejon Alba, ... BMC Public Health 13, 1-14, 2013 | 42 | 2013 |
| Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model M Bakır, Ö Türel, O Topachevskyi BMC health services research 12, 1-12, 2012 | 30 | 2012 |
| Cost-effectiveness analysis of pneumococcal vaccination with the pneumococcal polysaccharide NTHi protein D conjugate vaccine in the Philippines XH Zhang, MC Nievera, J Carlos, M Lucero, G Bibera, MI Atienza, ... Value in Health Regional Issues 3, 156-166, 2014 | 20 | 2014 |
| Assessing the preferences for criteria in multi-criteria decision analysis in treatments for rare diseases C Schey, MJ Postma, PFM Krabbe, O Topachevskyi, A Volovyk, ... Frontiers in public health 8, 162, 2020 | 14 | 2020 |
| The health economic impact of universal infant vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine as compared with 13 … KKC Lee, DBC Wu, O Topachevskyi, E Delgleize, R DeAntonio Value in health regional issues 2 (1), 64-74, 2013 | 14 | 2013 |
| Optimising the introduction of multiple childhood vaccines in Japan: a model proposing the introduction sequence achieving the highest health gains B Standaert, N Schecroun, O Ethgen, O Topachevskyi, Y Morioka, ... Health Policy 121 (12), 1303-1312, 2017 | 7 | 2017 |
| Estimation of supply side cost effectiveness threshold in Ukraine: perspective use in health care decision-making O Topachevskyi, O Piniazhko, O Lebega, O Oleshchuk Value in Health 21, S100, 2018 | 5 | 2018 |
| Implementation of health technology assessment at the stage of market access for pharmaceuticals in Ukraine OB Piniazhko, LI Kovtun, OM Zaliska, OM Oleshchuk, MV Leleka, ... Farmatsevtychnyi zhurnal, 45-58, 2020 | 3 | 2020 |
| Can a Multi-Criteria Decision (MCD) optimisation model help decision makers in the optimal selection of vaccines when expanding their universal mass vaccination programme? The … O Topachevskyi, B Standaert, LA Van Bellinghen, I Van Vlaenderen Value in Health 16 (7), A615, 2013 | 3 | 2013 |
| PRM170 Optimizing Public Health Decision Over Time: A Dynamic Budget Optimization Model With Multiple Criteria Decision Making O Ethgen, O Topachevskyi, M Connolly, B Standaert Value in Health 15 (7), A491, 2012 | 3 | 2012 |
| MSR9 moving from static to dynamic economic assessments: the process of migrating economic models to a web environment M Whittington, O Topachevskyi, A Volovyk Value in Health 25 (7), S519, 2022 | 1 | 2022 |
| POSA278 A Comprehensive Overview of New HTA Guideline for Medicines in Ukraine O Piniazhko, M Khmelyovska, A Masheiko, V Serediuk, O Topachevskyi, ... Value in Health 25 (1), S174, 2022 | 1 | 2022 |
| PIN114 estimation of quality-adjusted life years (QALY) losses associated with COVID-19 deaths in Ukraine V Serediuk, O Piniazhko, O Topachevskyi, T Dumenko, L Kovtun Value in Health 23, S562, 2020 | 1 | 2020 |
| Àêòóàë³çàö³ÿ ðåêîìåíäàö³é ùîäî øêàëè ð³âí³â âïëèâó íà áþäæåò ïðè îö³íö³ çàêóï³âë³ ë³êàðñüêèõ çàñîá³â â Óêðà¿í³ çà äàíèìè 2019 ðîêó OM Oleshchuk, OB Piniazhko, L² Kovtun, VV Serediuk, ÀÌ Masheiko, ... Ôàðìàöåâòè÷íèé ÷àñîïèñ, 76-83, 2020 | 1 | 2020 |
| PHS42 Cost-Effectiveness of Infant Vaccination With 10 and 13-Valent Pneumococcal Conjugate Vaccines in the Russian Federation AV Rudakova, S Sidorenko, SM Kharit, A Uskov, YV Lobzin, DG Shchurov, ... Value in Health 15 (7), A525, 2012 | 1 | 2012 |
| PRM63 Multiple Choices-How to Make Rational Decisions Across Several Interventions When Faced with Different Outcomes and Perspectives? O Topachevskyi, R Emerson, B Standaert Value in Health 14 (7), A432, 2011 | 1 | 2011 |
| MT11 Potential Budget Impact of Negative Pressure Wound Therapy with Instillation and Dwell Time Versus Control Therapies for Wound Management in Mexico D Campos, DV Hernandez, M Palka-Santini, V Siabro, O Topachevskyi Value in Health 26 (12), S428-S429, 2023 | | 2023 |
| HEALTH ECONOMIC MODEL FOR ESTIMATING THE DIRECT COST IMPACT OF ADOPTING AN ANTIMICROBIAL VASCULAR ACCESS SITE DRESSING IN ONCOLOGY PATIENTS WITH CENTRAL VENOUS CATHETER IN THE UK T Karpanen, I Siddall, A Khodakivska, O Topachevskyi, M Palka Santini VALUE IN HEALTH 25 (12), S142-S142, 2022 | | 2022 |
| EE196 Updated Recommendations for Budget Impact Scale for HTA System Implementation in Ukraine V Serediuk, O Piniazhko, O Topachevskyi, A Masheiko, O Oleshchuk, ... Value in Health 25 (12), S91, 2022 | | 2022 |
